Barclays PLC Clene Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.92 - $40.2 $469 - $20,502	-510 Reduced 78.46%	140 $0
Q3 2022 Nov 03, 2022	SELL	$0.33 - $73.0 $55 - $12,264	-168 Reduced 20.54%	650 $2,000
Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $5,273 - $10,345	-2,511 Reduced 75.43%	818 $2,000
Q1 2022 May 16, 2022	BUY	$2.42 - $4.42 $8,056 - $14,714	3,329 New	3,329 $13,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.